VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $825,505 | -45.5% | 30,676 | -39.1% | 0.01% | -40.0% |
| Q2 2023 | $1,515,528 | -44.8% | 50,333 | -40.7% | 0.01% | -50.0% |
| Q1 2023 | $2,744,306 | +265.0% | 84,831 | +223.4% | 0.02% | +233.3% |
| Q4 2022 | $751,806 | +50.7% | 26,231 | +26.8% | 0.01% | +50.0% |
| Q3 2022 | $499,000 | +5.9% | 20,693 | +20.2% | 0.00% | 0.0% |
| Q2 2022 | $471,000 | -37.5% | 17,212 | -12.5% | 0.00% | -20.0% |
| Q1 2022 | $754,000 | +8.0% | 19,661 | -9.8% | 0.01% | 0.0% |
| Q4 2021 | $698,000 | +16.3% | 21,803 | +7.2% | 0.01% | +25.0% |
| Q3 2021 | $600,000 | -12.4% | 20,348 | +1.0% | 0.00% | -20.0% |
| Q2 2021 | $685,000 | -0.9% | 20,156 | -5.3% | 0.01% | -16.7% |
| Q1 2021 | $691,000 | -36.7% | 21,275 | -29.8% | 0.01% | -40.0% |
| Q4 2020 | $1,092,000 | -13.3% | 30,316 | -5.8% | 0.01% | -28.6% |
| Q3 2020 | $1,260,000 | +31.8% | 32,176 | +23.6% | 0.01% | +7.7% |
| Q2 2020 | $956,000 | +113.9% | 26,025 | +34.1% | 0.01% | +116.7% |
| Q1 2020 | $447,000 | -51.9% | 19,406 | -38.9% | 0.01% | -40.0% |
| Q4 2019 | $930,000 | +81.6% | 31,767 | +65.7% | 0.01% | +66.7% |
| Q3 2019 | $512,000 | -40.0% | 19,169 | -42.6% | 0.01% | -40.0% |
| Q2 2019 | $853,000 | +17.8% | 33,384 | +3.4% | 0.01% | +11.1% |
| Q1 2019 | $724,000 | +3.4% | 32,282 | -2.7% | 0.01% | -10.0% |
| Q4 2018 | $700,000 | -17.6% | 33,189 | -27.6% | 0.01% | -9.1% |
| Q3 2018 | $849,000 | +5.9% | 45,864 | +25.5% | 0.01% | 0.0% |
| Q2 2018 | $802,000 | -0.1% | 36,534 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $803,000 | -7.6% | 36,534 | -2.3% | 0.01% | -8.3% |
| Q4 2017 | $869,000 | +2.7% | 37,391 | +1.5% | 0.01% | 0.0% |
| Q3 2017 | $846,000 | +14.6% | 36,833 | +10.2% | 0.01% | 0.0% |
| Q2 2017 | $738,000 | +32.5% | 33,425 | +36.8% | 0.01% | +20.0% |
| Q1 2017 | $557,000 | +178.5% | 24,430 | +222.9% | 0.01% | +150.0% |
| Q3 2016 | $200,000 | – | 7,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |